Helping you offer targeted cancer risk assessment in-house
Inherited genetic mutations play a major role in 5 to 10% of all cancers. As a result, many experts recommend genetic testing for individuals with a personal or family history that suggests an increased cancer risk for one or more hereditary cancers. Whether you’re already running NGS tests or are looking to update Sanger sequencing tests to current NGS methods, our advanced technology and regulatory expertise can help you set up an efficient and customized analysis, interpretation and clinical reporting workflow for high volume testing for targeted cancer risk assessment. Bringing reimbursable, profitable tests in-house while providing superior service to your clients.
Panel content customized for your testing strategy
With mutations linked to more than 50 hereditary cancers, a broad range of testing strategies is possible. Using the latest content integrated from top variant-disease and gene-disease association databases, we work with you to build the most appropriate workflow and filters for your desired strategy. Whether your strategy is an economical two gene BRCA1 plus BRCA2 panel for inherited breast and ovarian cancer or a 100+ gene panel for broader cancer risk assessment, we have the necessary expertise and bio-banked samples to build and validate an appropriate genomic test in a matter of weeks.
Pipelines built for advanced analysis and interpretation
Our Genomic Intelligence® platform is designed to seamlessly integrate with your in-house sequencer, automating the sample to clinical report process. Patient information and FASTQ sequence data is securely transferred to our HIPAA-compliant cloud platform where gold-standard tools and best practices, combined with proprietary algorithms, accurately and efficiently identify small nucleotide changes and structural variants within a single test. As a result, comprehensive coverage of all relevant mutations is assured.
Automated, customized clinical reports
Our integrated Genomic Intelligence® diagnostic console makes it easy to review and interpret found variants. With a single click, a clinical report fully customized with your organization’s logo and medicolegal language is generated. Our board-certified medical geneticists can generate and sign the clinical reports, based on their interpretation of the results. Or, at any time, we can train your clinicians to use the console to perform their own interpretation and generate their own clinical reports. The choice is yours.